Adaptive Biotechnologies
ADPT
$8.75
Share price
0.57%
Change (1 day)
-78.27%
Change (1 year)
Categories
Revenue for Adaptive Biotechnologies (ADPT)
Revenue in 2022 (TTM): $0.15 B
According to Adaptive Biotechnologies 's latest financial reports the company's current revenue (TTM) is $0.15 B. In 2021 the company made a revenue of $0.15 B an increase over the years 2020 revenue that were of $0.09 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Adaptive Biotechnologies from 2018 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.15 B | 0.12% |
| 2021 | $0.15 B | 56.88% |
| 2020 | $0.09 B | 15.65% |
| 2019 | $0.08 B | 52.83% |
| 2018 | $0.05 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | $57.08 B | 36,840.37% | 🇺🇸 USA |
 Premier PINC | $1.57 B | 918.44% | 🇺🇸 USA |
 Community Health Systems
CYH | $12.46 B | 7,967.46% | 🇺🇸 USA |
 Select Medical Holdings SEM | $6.24 B | 3,940.78% | 🇺🇸 USA |